A pathological examination revealed an estrogen receptor-positive (ER-positive), progesterone receptor-positive (PgR-positive), and human epidermal growth factor receptor 2-positive (HER2-positive) invasive ductal carcinoma. The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.